RobertATerkeltaubMD

PubMed

• Describing calcium pyrophosphate deposition: undoing the tower of Babel!
  Silvia Sirotti, Georgios Filippou, Robert Terkeltaub> ;Current Opinion in Rheumatology. 2024 May 1
• The NADase CD38 is a central regulator in gouty inflammation and a novel druggable therapeutic target.
  Paulo Gil Alabarse, Patricia Oliveira, Huaping Qin, Tiffany Yan, Marie Migaud, Ru Liu-Bryan, Robert Terkeltaub> ;Inflammation Research. 2024 Mar 16
• The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout.
  Chio Yokose, Natalie McCormick, Abhishek Abhishek, Nicola Dalbeth, Tristan Pascart, Frédéric Lioté, Angelo Gaffo, John FitzGerald, Robert Terkeltaub, Meghan E Sise, Ja...> ;Nature Reviews. Rheumatology. 2024 Apr 1
• Hyperuricemia Subtypes Classified According to Renal Uric Acid Handling Manifesting Distinct Phenotypic and Genetic Profiles in People With Gout.
  Han Qi, Mingshu Sun, Robert Terkeltaub, Tony R Merriman, Haibing Chen, Zhiqiang Li, Aichang Ji, Xiaomei Xue, Wenyan Sun, Can Wang, Xinde Li, Yuwei He, Lingling Cui, Ni...> ;Arthritis & Rheumatology. 2024 Feb 27
• Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial.
  Hiddo J L Heerspink, Austin G Stack, Niels Jongs, Magnus Bjursell, Noha Maklad, Shira Perl, Olof Eklund, Tord Rikte, C David Sjöström, Vlado Perkovic, , Robert Terkelt...> ;Journal of the American Society of Nephrology. 2024 Feb 20
• Synthesis, Detection, and Metabolism of Pyridone Ribosides, Products of NAD Overoxidation.
  Faisal Hayat, J Trey Deason, Ru Liu Bryan, Robert Terkeltaub, Weidan Song, W Lee Kraus, Janice Pluth, Natalie R Gassman, Marie E Migaud> ;Chemical Research in Toxicology. 2024 Feb 19
• Sustained xanthine oxidase inhibitor treat to target urate lowering therapy rewires a tight inflammation serum protein interactome.
  Sanchez, C., Campeau, A., Liu-Bryan, R., O'Dell, J., Gonzalez, D., Mikuls, T., Terkeltaub, R.> ;Research Square. 2024 Jan 2
• Superiority of Low-Dose Benzbromarone Add-On to Low-Dose Febuxostat Compared With Febuxostat Monotherapy in Gout With Combined-Type Hyperuricemia.
  Xue, X., Sun, M., Yan, F., Dalbeth, N., He, Y., Li, X., Qi, H., Chen, Y., Yuan, X., Li, M., Ji, A., Li, C., Terkeltaub, R.> ;Arthritis Care & Research. 2023 Dec 21
• Response to febuxostat according to clinical subtypes of hyperuricemia: a prospective cohort study in primary gout.
  Qi, H., Sun, M., Xue, X., Li, X., Cui, L., He, Y., Yan, F., Sun, R., Chen, Y., Jia, Z., Cheng, X., Ma, L., Liu, T., Dalbeth, N., Li, C., Terkeltaub, R.> ;Arthritis Research & Therapy. 2023 Dec 11
• 2 citations
  Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review.
  Robert Terkeltaub> ;Drugs. 2023 Nov 1
• COVID-19 Vaccination and Gout Flare Risk in Patients With Infrequent or Frequent Flares: A Prospective Cohort Study.
  Yuwei He, Xiaomei Xue, Nicola Dalbeth, Robert Terkeltaub, Ying Chen, Fei Yan, Lei Pang, Xinde Li, Xuan Yuan, Xiaoyu Cheng, Changgui Li, Mingshu Sun> ;Arthritis Care & Research. 2024 Jan 1
• 4 citations
  The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease.
  Abhishek Abhishek, Sara K Tedeschi, Tristan Pascart, Augustin Latourte, Nicola Dalbeth, Tuhina Neogi, Amy Fuller, Ann Rosenthal, Fabio Becce, Thomas Bardin, Hang Korng...> ;Arthritis & Rheumatology. 2023 Oct 1
• 3 citations
  The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease.
  Abhishek Abhishek, Sara K Tedeschi, Tristan Pascart, Augustin Latourte, Nicola Dalbeth, Tuhina Neogi, Amy Fuller, Ann Rosenthal, Fabio Becce, Thomas Bardin, Hang-Korng...> ;Annals of the Rheumatic Diseases. 2023 Oct 1
• 3 citations
  The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.
  Herbert S B Baraf, Puja P Khanna, Alan J Kivitz, Vibeke Strand, Hyon K Choi, Robert Terkeltaub, Nicola Dalbeth, Wesley DeHaan, Rehan Azeem, Peter G Traber, Robert T Ke...> ;Rheumatology. 2024 Apr 2
• Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares.
  Ming Wang, Rui Li, Han Qi, Lei Pang, Lingling Cui, Zhen Liu, Jie Lu, Rong Wang, Shuhui Hu, Ningning Liang, Yongzhen Tao, Nicola Dalbeth, Tony R Merriman, Robert Terkel...> ;Arthritis & Rheumatology. 2023 Dec 1
• 1 citations
  Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population-Based, Prospective Study and Mendelian R...
  Amit D Joshi, Natalie McCormick, Chio Yokose, Bing Yu, Adrienne Tin, Robert Terkeltaub, Tony R Merriman, A Heather Eliassen, Gary C Curhan, Laura M Raffield, Hyon K Choi> ;Arthritis & Rheumatology. 2023 Sep 1
• 5 citations
  Serum Urate-Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Trial.
  Robert Terkeltaub, Jisoo Lee, Jiyoung Min, Seonghye Shin, Kenneth G Saag> ;Arthritis & Rheumatology. 2023 Jul 1
• 3 citations
  Proton-Pump Inhibitors and Risk of Calcium Pyrophosphate Deposition in a Population-Based Study.
  Jean W Liew, Christine Peloquin, Sara K Tedeschi, David T Felson, Yuqing Zhang, Hyon K Choi, Robert Terkeltaub, Tuhina Neogi> ;Arthritis Care & Research. 2022 Dec 1
• 12 citations
  Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underex...
  Fei Yan, Xiaomei Xue, Jie Lu, Nicola Dalbeth, Han Qi, Qing Yu, Can Wang, Mingshu Sun, Lingling Cui, Zhen Liu, Yuwei He, Xuan Yuan, Ying Chen, Xiaoyu Cheng, Lidan Ma, H...> ;Arthritis & Rheumatology. 2022 Dec 1
• 10 citations
  Amplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of Hyperuricemia.
  Khaled Elsaid, Tony R Merriman, Leigh-Ana Rossitto, Ru Liu-Bryan, Jacob Karsh, Amanda Phipps-Green, Gregory D Jay, Sandy Elsayed, Marwa Qadri, Marin Miner, Murray Cadz...> ;Arthritis & Rheumatology. 2023 May 1
• 24 citations
  Enhancing untargeted metabolomics using metadata-based source annotation.
  Gauglitz, J., West, K., Bittremieux, W., Williams, C., Weldon, K., Panitchpakdi, M., Di Ottavio, F., Aceves, C., Brown, E., Sikora, N., Jarmusch, A., Martino, C., Trip...> ;Nature Biotechnology. 2022 Dec 1
• 1 citations
  Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study.
  Shuhui Hu, Mingshu Sun, Maichao Li, Xiaomei Xue, Robert Terkeltaub, Can Wang, Ming Wang, Jie Lu, Zijing Ran, Hailong Li, Aichang Ji, Wenyan Sun, Xinde Li, Yuwei He, Zh...> ;Rheumatology. 2023 Jul 5
• 1 citations
  Palpable tophi and more comorbidities associated with adherence to urate-lowering medical therapy in a Chinese gout cohort.
  Shuhui Hu, Robert Terkeltaub, Mingshu Sun, Xiaopeng Ji, Zhiyuan Li, Zijing Ran, Yushuang Li, Hui Zhang, Wenyan Sun, Changgui Li, Jie Lu> ;Joint Bone Spine. 2022 Nov 1
• 2 citations
  A fly GWAS for purine metabolites identifies human FAM214 homolog medusa, which acts in a conserved manner to enhance hyperuricemia-driven pathologies by modulating pu...
  Tyler A U Hilsabeck, Ru Liu-Bryan, Tracy Guo, Kenneth A Wilson, Neelanjan Bose, Daniel Raftery, Jennifer N Beck, Sven Lang, Kelly Jin, Christopher S Nelson, Tal Oron, ...> ;Geroscience. 2022 Aug 1
• 6 citations
  Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination.
  Jie Lu, Yuwei He, Robert Terkeltaub, Mingshu Sun, Zijing Ran, Xinmiao Xu, Can Wang, Xinde Li, Shuhui Hu, Xiaomei Xue, Fei Yan, Hui Zhang, Huiyong Yin, Yongyong Shi, Ni...> ;Annals of the Rheumatic Diseases. 2022 Aug 1
• Join now to see all

Journal Articles

• Authors’ Reply to Letter to the Editor  
  Tuhina Neogi, Robert Terkeltaub, Arthritis & Rheumatology
• Arhalofenate Acid Inhibits Monosodium Urate Crystal-Induced Inflammatory Responses Through Activation of AMP-Activated Protein Kinase (AMPK) Signaling  
  Robert Terkeltaub, MD, BioMed Central
• Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES) Trial and Associated FDA Public Sa...  
  Robert Terkeltaub, Tuhina Neogi, Arthritis & Rheumatology